- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
AJMC® in the Press, May 14, 2021
Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.
An article by The City Sentinel cited a study published in The American Journal of Managed Care® (AJMC®). The study, “Managed Care COVID-19 Outcomes in a Population Health Program,” found similar COVID-19 risk factors between managed care patients and the general population, although a population health program was associated with decreased mortality.
A piece by Latin Post featured AJMC.com's “A Timeline of COVID-19 Vaccine Developments in 2021.” The timeline provides weekly updates on the latest news regarding COVID-19 vaccine distribution this year.
An article posted on Baystreet.ca cited an AJMC® study titled, “Integrated Delivery Systems: The Cure for Fragmentation.” The study indicated that while no single approach or public policy will fix the fragmented health care system, integrated delivery systems represent an important step in the right direction.
Global Trends in Ovarian Cancer Incidence Highlight Regional, Histological Variations
January 7th 2025Between 1988 and 2017, there were significant global variations and trends in ovarian cancer incidence and its subtypes, influenced by genetic, reproductive, and socioeconomic factors.
Read More
Managed Care Cast Presents: BTK Inhibitors in Treatment-Naive Patients With CLL and MCL
December 26th 2024A trio of experts discuss the treatment of chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL) with Bruton tyrosine kinase (BTK) inhibitors, including cost considerations.
Listen
Decisions and Precision in Value-Based Cancer Care
January 7th 2025An Institute for Value-Based Medicine regional event in Houston, Texas, covered inconsistencies with the integration of precision medicine in oncology practices, the evolution of treatment for multiple myeloma, and more.
Read More
